Scout by Fusion42
Fusion42 Raise Wire
Money Report
Who RaisedWeekly · Mon 08:30 UTCEarly VelocityWeekly · Thu 08:30 UTCValuation & DilutionBi-weekly · Wed 08:30 UTC
Benchmarks
Benchmarks HomeStartupsRoundsStages
AI Startup IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Money Report

All editionsWho RaisedWeekly · Mon 08:30 UTCEarly VelocityWeekly · Thu 08:30 UTCValuation & DilutionBi-weekly · Wed 08:30 UTC

Database & benchmarks

Benchmarks HomeStartupsGeographiesRoundsStagesAI Startup IndexCapital Flow Index

Account

Sign in
← Back

City Therapeutics

Cambridge, United States

Digital HealthBiotech

◆ Location

Cambridge, United States

◆ Founded

2024

◆ Team size

11-50

◆ Links

Website ↗

◆ About City Therapeutics

Next-generation RNAi startup founded by former Alnylam executives developing clinical-stage RNAi medicines.

◆ What sets it apart

It uses next-generation siRNA engineering and a novel RNAi targeting approach intended to make medicines more efficient, easier to deliver, and cheaper to manufacture.[2][4]

◆ Sectors

Digital HealthBiotech

◆ Business

Modeltransactional

Customerpatients and healthcare providers through clinical-stage RNAi medicines

◆ Notable

  • Launched with a $135 million Series A financing.[2]
  • Built a pipeline of innovative RNAi therapeutics with a lead program expected to enter clinical development around the end of 2025.[2]

◆ Explore the market

Digital HealthBiotechUnited States

◆ FAQ

What does City Therapeutics do?

Next-generation RNAi startup founded by former Alnylam executives developing clinical-stage RNAi medicines.

Where is City Therapeutics based?

City Therapeutics is based in Cambridge, United States, founded in 2024.

Who has invested in City Therapeutics?

Investors in City Therapeutics include ARCH Venture Partners, Fidelity Management & Research Company, Invus, Slate Path Capital, Rock Springs Capital, Regeneron Ventures and AN Ventures.